1 unchanged sentence
Market Information
−Removed: Our common stock has traded on the Nasdaq stock market under the symbol “MDGL” since July 25, 2016.
+Added: Our common stock trades on the Nasdaq Stock Market under the symbol “MDGL.”
As of December 31, 2024, there were approximately 23 holders of record of our common stock.
4 unchanged sentences
Any future determination to pay cash dividends will be at the discretion of our board of directors and will depend on our financial condition, results of operations, contractual restrictions, capital requirements, and other factors that our board of directors deems relevant.
+Added: Securities Authorized for Issuance Under Equity Compensation Plans
+Added: The information required by Item 5 of Form 10-K regarding equity compensation plans is incorporated herein by reference to Item 12 of Part III of this Annual Report.
+Added: Purchases of Equity Securities by the Issuer and Affiliated Purchasers
+Added: We did not purchase any of our registered equity during the period covered by this Annual Report.
+Added: Unregistered Sales of Securities
+Added: During the year ended December 31, 2024, we did not issue or sell any unregistered securities.
Stock Performance Graph
−Removed: The graph set forth below compares the cumulative total stockholder return on our common stock between January 1, 2019 and December 31, 2023, with the cumulative total return of (a) the Nasdaq Biotechnology Index and (b) the Nasdaq Composite Index, over the same period.
−Removed: This graph assumes the investment of $100 on January 1, 2019 in our common stock, the Nasdaq Biotechnology Index and the Nasdaq Composite Index and assumes the reinvestment of dividends, if any.
+Added: The graph set forth below compares the cumulative total stockholder return on our common stock between December 31, 2019 and December 31, 2024, with the cumulative total return of (a) the Nasdaq Biotechnology Index and (b) the Nasdaq Composite Index, over the same period.
+Added: This graph assumes the investment of $100 on December 31, 2019 in our common stock, the Nasdaq Biotechnology Index and the Nasdaq Composite Index and assumes the reinvestment of dividends, if any.
The comparisons shown in the graph below are based upon historical data.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.